EI
ODT

EAM Investors’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

EAM Investors’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-31,564
Closed -$822K – 346
2019
Q3 		$822K Buy
+31,564
New +$1.06M 0.22% 201

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

EAM Investors's ODT Position: Q4 2019 in Review

EAM Investors sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2019, closing a stake of 31,564 shares — an estimated $822K sold.

EAM Investors first reported a position in ODT in Q3 2019 and held it in 1 quarter. The position peaked at $822K in Q3 2019. 88 funds tracked by Wall St. Rank hold ODT as of Q4 2019.

  • EAM Investors reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • EAM Investors sold 31,564 Odonate Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $822K.
  • EAM Investors first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • EAM Investors's Odonate Therapeutics, Inc. Common Stock position peaked at $822K in Q3 2019.
  • 88 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2019.

Based on EAM Investors's 13F filing for Q4 2019, filed 11 Feb 2020.